Trupanion (TRUP) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
9 Apr, 2026Executive summary
Achieved record year in 2025 with total revenue of $1.44 billion, up 12% year-over-year, and strong Q4 performance; subscription revenue reached $989.3 million, up 16%.
Ended 2025 with nearly 1.1 million pets protected and over $3.5 billion paid in veterinary invoices historically.
Net income for 2025 was $19.4 million, reversing a net loss of $9.6 million in 2024, aided by a $7.8 million realized gain from a preferred stock exchange.
Focused on brand expansion, member retention, and new product development to drive future growth.
Achieved four consecutive quarters of higher retention and accelerating gross pet adds.
Financial highlights
Q4 2025 total revenue was $376.9 million, up 12% year-over-year; subscription revenue was $261.4 million, up 15%.
Free cash flow for Q4 was $25.3 million, up from negative $1.9 million in Q4 2024; full-year free cash flow was $75.4 million, nearly doubling year-over-year.
Net income for Q4 was $5.6 million ($0.13 per share), up from $1.7 million ($0.04 per share) last year.
Ended 2025 with $370.7 million in cash and short-term investments and reduced debt to $111.8 million.
Subscription business margin reached 14.7% for the year, up from 12.6% in 2024.
Outlook and guidance
2026 total revenue expected between $1.55 billion and $1.582 billion; subscription revenue between $1.117 billion and $1.137 billion (14% growth midpoint).
Adjusted operating income for 2026 projected at $173–$187 million (19% growth midpoint).
Q1 2026 revenue guidance: $376–$382 million; subscription revenue $265–$268 million; AOI $38–$41 million (27% growth midpoint).
Guidance assumes veterinary inflation in line with current trends and uses a 73% USD/CAD conversion rate.
Management highlighted four consecutive quarters of higher retention and accelerating gross pet adds, supporting confidence in the next strategic plan.
Latest events from Trupanion
- Leading pet insurer drives growth with strong financials, tech innovation, and global expansion.TRUP
Investor presentation - Q2 2026 revenue up 11%, adjusted operating income up 24%, $100M buyback and $44M dividend.TRUP
Q2 2026 - Margin expansion, capital surplus, and tech-driven efficiency set the stage for disciplined growth.TRUP
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024 - Q1 2026 revenue up 12% to $384M, AOI up 29%, and margins reached record highs.TRUP
Q1 2026 - Shareholders will vote on directors, auditor ratification, and executive pay, with strong governance and oversight.TRUP
Proxy filing - Key votes include director elections, auditor ratification, and executive pay approval.TRUP
Proxy filing - Strong growth, data-driven innovation, and new products position the company for market expansion.TRUP
47th Annual Raymond James Institutional Investor Conference - Record profit growth, high retention, and global expansion drive strong 2025 outlook.TRUP
Investor Day 2025 - Sustainable, data-driven growth and international expansion are prioritized, with vet partnerships central.TRUP
Investor Day 2024